Currently out of the existing stock ratings of John Boris, 29 are a BUY (85.29%), 5 are a HOLD (14.71%).

John Boris

Work Performance Price Targets & Ratings Chart

Analyst John Boris, carries an average stock price target met ratio of 70% that have a potential upside of 46.58% achieved within 619 days. Previously, John Boris worked at TRUIST.

John Boris’s has documented 63 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Common Stock at 11-Jul-2019.

Wall Street Analyst John Boris

Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 2/18/2015. The price target of $2 was fulfilled within 22 days with a profit of $0.69 (52.67%) receiving and performance score of 23.94.

Average potential price target upside

of $49.17 (69.62%) on ABBV (ABBVIE).
of $31.33 (44.51%) on LLY (ELI LILLY AND COMPANY).
of $19.36 (41.85%) on MRK (MERCK MPANY).

AMRX Amneal Pharmaceuticals, Common Stock MRK Merck mpany JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company ABBV AbbVie AGN Allergan plc AMRN Amarin PLC PFE Pfizer SUPN Supernus Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Balaji Prasad (BARCLAYS)